Adenocarcinoma is a type of cancer that originates in glandular tissue, which lines organs and forms the secretory portions of glands. It commonly affects organs like the lungs, colon, prostate, pancreas, and breast. Research in adenocarcinoma focuses on understanding genetic mutations and molecular pathways that drive its development and progression. Advances in genomic sequencing have identified key mutations, such as those in the KRAS, EGFR, and BRAF genes, which are pivotal in personalized medicine approaches. Current studies also explore the tumor microenvironment and its role in cancer growth and metastasis. Novel treatments, including targeted therapies and immunotherapies, are being developed and tested in clinical trials, aiming to improve survival rates and quality of life for patients with adenocarcinoma.
Title : RNA binding proteins in the pathogenesis of pediatric cancer
Atif A Ahmed, University of Washington-Seattle Children’s Hospital, United States
Title : A novel mRNA genomic technology for precision medicine, early cancer diagnosis, prognosis, treatment follow-up and cancer gene therapy
Rajvir Dahiya, University of California San Francisco, United States
Title :
Jianhua Luo, University of Pittsburgh, United States
Title : Biosensor-based detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Principles of oral rehabilitation in H&N cancer patients
Pietro Salvatori, Independent H&N Surgeon, Italy
Title :
Marika Crohns, Impactful Innovations Management Consultants LLC, United Arab Emirates